5 Most Valuable Pipeline Drugs in Development -- and the Stocks Poised to Profit
Thousands of experimental drugs are in development right now. Most of them will never make it to market. Some that do won't achieve tremendous commercial success. But there are a few drugs in pipelines right now that will go on to generate billions of dollars in sales.
Market research company EvaluatePharma recently released its World Preview 2019, Outlook to 2024 report. This report identified the current candidates that the company projects will be the biggest winners in 2024. Here are the five most valuable pipeline drugs in development -- and the stocks that are poised to profit from these drugs.